Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) P/S ratio
As of 16 October 2026, Intuitive Surgical, Inc. (ISRG) trades at a P/S ratio of 13.7×. Over the past ten years it has ranged from 7.3× (October 2015) to 26.0× (January 2025); the current reading is higher than 33% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 3.4×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 20.1× | (9.53%) |
| FY2024 | 22.2× | 36.05% |
| FY2023 | 16.3× | 7.45% |
| FY2022 | 15.2× | (32.23%) |
| FY2021 | 22.4× | 2.00% |
| FY2020 | 22.0× | 44.22% |
| FY2019 | 15.2× | 4.18% |
| FY2018 | 14.6× | 9.47% |
| FY2017 | 13.4× | 47.06% |
| FY2016 | 9.1× | 6.88% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 12.8× | (17.46%) |
| Mar 2026 | 15.5× | (23.02%) |
| Dec 2025 | 20.1× | 21.04% |
| Sep 2025 | 16.6× | (22.11%) |
| 42 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| MDLN Medline Inc. compare | 1.0× |
| BAX Baxter International Inc. compare | 1.1× |
| SOLV Solventum Corporation compare | 1.8× |
| BDX Becton, Dickinson and Company compare | 2.4× |
| ALC Alcon compare | 3.0× |
| RMD ResMed Inc. compare | 6.2× |
| WST West Pharmaceutical Services, Inc. compare | 8.1× |
| RGEN Repligen Corporation compare | 12.6× |
| ISRG Intuitive Surgical, Inc. | 13.7× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.4× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement